AGTR2 and metabolic syndrome: In an animal model of metabolic syndrome, a higher expression of AT1 and MasR receptors was observed, which mediate anti‐inflammatory and cardioprotective actions, and the lower expression of the proinflammatory receptor AT2 after the administration of candersatan and captopril.52